HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Stacey Selected Research

David Stacey Research Topics

Disease

3Bipolar Disorder (Manic Depressive Psychosis)
05/2024 - 01/2022
3Mental Disorders (Mental Disorder)
02/2024 - 01/2022
3Inflammation (Inflammations)
01/2023 - 01/2022
2Schizophrenia (Dementia Praecox)
02/2024 - 01/2022
2Vascular Diseases (Vascular Disease)
04/2022 - 01/2022
2Major Depressive Disorder (Major Depressive Disorders)
01/2022 - 10/2013
2Coronary Disease (Coronary Heart Disease)
01/2019 - 01/2018
2Mood Disorders (Mood Disorder)
01/2018 - 12/2015
1Ovarian Neoplasms (Ovarian Cancer)
02/2024
1Rheumatoid Arthritis
01/2023
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2023
1Multiple Sclerosis
01/2023
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2022
1Venous Thromboembolism
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
10/2021
1Metabolic Diseases (Metabolic Disease)
10/2021
1Myocardial Infarction
01/2019
1Atherosclerotic Plaque (Atheroma)
01/2018
1Cognitive Dysfunction
01/2018
1Necrosis
01/2017

Drug/Important Bio-Agent (IBA)

3LithiumIBA
05/2024 - 01/2018
3Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2018
3LipidsIBA
10/2021 - 01/2018
2Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2018
2Endothelial Protein C ReceptorIBA
04/2022 - 01/2022
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2022
2CytokinesIBA
01/2018 - 12/2015
1Arachidonic Acid (Vitamin F)IBA
02/2024
1Blood Proteins (Serum Proteins)IBA
01/2023
1Lymphotoxin-alpha (Lymphotoxin)IBA
01/2023
1MicroRNAs (MicroRNA)IBA
01/2022
1Circular RNAIBA
01/2022
1Piwi-Interacting RNAIBA
01/2022
1Antidepressive Agents (Antidepressants)IBA
01/2022
1Protein CIBA
01/2022
1Psychotropic Drugs (Psychoactive Drugs)IBA
01/2022
1Antipsychotic Agents (Antipsychotics)IBA
01/2022
1mesoglycanIBA
01/2022
1Cyclin D3IBA
01/2018
1Apolipoproteins B (ApoB)IBA
01/2018
1ThioredoxinsIBA
01/2018
1C-Reactive ProteinIBA
01/2017
1InterleukinsIBA
01/2017
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
10/2013